Biontech

Latest Stories

In this March 6, 2021, file photo, boxes stand next vials of Johnson & Johnson COVID-19 vaccine in the pharmacy of National Jewish Hospital for distribution in east Denver. The drug maker decided Tuesday, April 13, to delay deliveries to Europe after the American regulator recommended a pause in the vaccine's use in the United States while very rare blood clot cases are examined. (AP Photo/David Zalubowski, File)

Europe scrambles as J&J vaccine delay deals another blow

By JOSEPH WILSON - Associated Press

Cole Smith receives a Moderna variant vaccine shot from clinical research nurse Tigisty Girmay at Emory University's Hope Clinic, on Wednesday afternoon, March 31, 2021, in Decatur, Ga. Smith, who received Moderna's original vaccine a year ago in a first-stage study, said returning wasn’t a tough decision. “The earlier one, it was a great success and, you know, millions of people are getting vaccinated now. ... If we’re helping people with the old one, why not volunteer and help people with the new one?” (AP Photo/Ben Gray)

Tweaked COVID vaccines in testing aim to fend off variants

By LAURAN NEERGAARD - Associated Press

A health official wearing protective suits tries to help visitors at a temporary screening clinic for coronavirus in Seoul, South Korea, Saturday, April 10, 2021. (AP Photo/Lee Jin-man)

The Latest: Michigan pushing for more vaccines amid spike

By The Associated Press - Associated Press

Chinese residents, some wearing masks, pass by a coronavirus vaccination center in Beijing Friday, April 9, 2021. In a rare admission of the weakness of Chinese coronavirus vaccines, the country's top disease control official says their effectiveness is low and the government is considering mixing them to give them a boost. (AP Photo/Ng Han Guan)

China coronavirus vaccines ‘don’t have very high protection rates’

By Joe McDonald and Huizhong Wu - Associated Press

A worker opens a package of coronavirus vaccine made by a Sinopharm subsidiary during a COVID-19 vaccination session for resident foreign journalists at a vaccination center in Beijing, Tuesday, March 23, 2021. Chinese medical firm Sinovac said its COVID-19 vaccine is safe in children ages 3-17, based on preliminary data, and it has submitted the data to Chinese drug regulators. State-owned Sinopharm, who has two COVID-19 vaccines, is also investigating the effectiveness of its vaccines in children. (AP Photo/Mark Schiefelbein)

Top Chinese official admits vaccines have low effectiveness

By JOE McDONALD and HUIZHONG WU - Associated Press

Australian Prime Minister Scott Morrison, left, addresses the media at a press conference as Department of Health Secretary Dr Brendan Murphy watches at Parliament House in Canberra, Australia, Friday, April 9, 2021. Australia says it has finalized a deal to buy an extra 20 million doses of the Pfizer vaccine as the nation rapidly pivots away from its earlier plan to rely mainly on the AstraZeneca vaccine. (Mick Tsikas/AAP Image via AP)

The Latest: Navajo Nation issues weekend stay-at-home order

By The Associated Press - Associated Press

FILE- In this Monday, March. 22, 2021, file photo, Hong Kong Chief Executive Carrie Lam receives the second dose of the Sinovac Biotech COVID-19 vaccine at a Central Government office in Hong Kong. Hong Kong's sudden suspension of a COVID-19 vaccine developed by Pfizer and BioNTech is another blow to a vaccination program already struggling against a wall of public distrust. Hong Kong on Wednesday, March 24, 2021, suspended use of the Pfizer vaccine, distributed by Chinese pharmaceutical firm Fosun Pharma, after defective packaging such as loose vial lids and cracks on bottles were found in one of two batches of the vaccine. (AP Photo/Vincent Yu, File)

Hong Kong to resume Pfizer shots after packaging defects

By ZEN SOO - Associated Press

In this Dec. 22, 2020, photo, provided by Richard Chung, his son Caleb Chung receives the first dose of Pfizer coronavirus vaccine or placebo as a trial participant for kids ages 12-15, at Duke University Health System in Durham, N.C. Pfizer says its COVID-19 vaccine is safe and strongly protective in kids as young as 12. The announcement Wednesday, March 31, 2021 marks a step toward possibly beginning shots in this age group before the next school year. (Richard Chung via AP)

Pfizer says its COVID-19 vaccine protects younger teens

By Lauran Neergaard - Associated Press

In this Dec. 22, 2020, photo, provided by Richard Chung, his son Caleb Chung receives the first dose of Pfizer coronavirus vaccine or placebo as a trial participant for kids ages 12-15, at Duke University Health System in Durham, N.C. Pfizer says its COVID-19 vaccine is safe and strongly protective in kids as young as 12. The announcement Wednesday, March 31, 2021 marks a step toward possibly beginning shots in this age group before the next school year. (Richard Chung via AP)

Pfizer: COVID-19 vaccine 100% effective in ages 12-15

By Tom Howell Jr. - The Washington Times

A laboratory worker simulates the workflow in a cleanroom of the BioNTech Corona vaccine production in Marburg, Germany, during a media day on Saturday, March 27, 2021. BioNTech, the Mainz-based company that invented the messenger RNA-based vaccine, is busily ramping up its production capabilities at the company's new production facility in Marburg. BioNTech originally expected the plant could turn out 700 million doses per year; it has since upgraded its expectations to a billion a year. (AP Photo/Michael Probst)

Amid AstraZeneca setback, Germany banks on homegrown vaccine

By FRANK JORDANS and DAVID McHUGH - Associated Press

Pfizer to break ground on new Michigan production facility

Associated Press

EU medicines regulator approves new vaccine production sites

Associated Press

FILE - In this Feb. 23, 2021, file photo, health workers look at a vial and a syringe while administering a dose of the Sinovac Biotech COVID-19 vaccine at a community vaccination center in Hong Kong. Hong Kong's sudden suspension of a COVID-19 vaccine developed by Pfizer and BioNTech is another blow to a vaccination program already struggling against a wall of public distrust. Hong Kong on Wednesday, March 24, 2021, suspended use of the Pfizer vaccine, distributed by Chinese pharmaceutical firm Fosun Pharma, after defective packaging such as loose vial lids and cracks on bottles were found in one of two batches of the vaccine. (Paul Yeung/Pool Photo via AP, File)

Hong Kong vaccination drive struggles to gain public trust

By ZEN SOO - Associated Press

Hong Kong suspends vaccinations of BioNTech shots after defective packaging found in one batch

Associated Press

People queue up outside a vaccination center for BioNTech in Hong Kong Wednesday, March 24, 2021. Hong Kong suspended vaccinations using Pfizer shots - known as BioNTech shots in the city - on Wednesday after they were informed by its distributor Fosun that one batch had defective bottle lids. (AP Photo/Vincent Yu)

Hong Kong halts use of Pfizer vaccine, cites defective lids

By ZEN SOO - Associated Press

A health worker prepares a Pfizer vaccine during a COVID-19 vaccination campaign at the vaccination center in the town of Utena, some 100km (62.2 miles) north of the capital Vilnius, Lithuania, Wednesday, March 17, 2021. Lithuania has decided to temporarily suspend vaccination with Covid-19 vaccine developed by AstraZeneca. (AP Photo/Mindaugas Kulbis)

WHO, European Commission offer support for AstraZeneca vaccine

By Tom Howell Jr. - The Washington Times

Trashelle Miro, Albertsons pharmacy manager, holds a vial of the Johnson &amp; Johnson COVID-19 vaccine at an Albertsons supermarket pharmacy in Las Vegas Thursday, March 11, 2021. (Steve Marcus/Las Vegas Sun via AP)

WHO adds Johnson & Johnson COVID-19 vaccine to arsenal

By Shen Wu Tan - The Washington Times

Nurse Baerbel, center, from the mobile vaccination team injects Gustavs Owe with the Corona vaccine from Biontech/Pfizer in the office of island doctor Mueller in Hiddensee, Germany, Wednesday, March 10, 2021. Doctor Anja Schumacher advises the patient. On the Baltic Sea island of Hiddensee, more than 120 people are vaccinated against the corona virus. In addition to people with the highest vaccination priority - for example, people over 80 years of age or high-risk medical personnel - the beneficiaries also include parts of the school and daycare staff. (Jens Buettner/dpa via AP)

EU gets extra vaccine doses to tackle virus border clusters

By SAMUEL PETREQUIN - Associated Press

Amid ‘historic’ rollout, UN vaccine project faces some delay

By JAMEY KEATEN - Associated Press

Ontario says seniors won’t get AstraZeneca vaccine

Associated Press